Search research articles
Contact Us
Filters
Showing results (211-220 of 272) with videos related to
Page
of 28
Sort By:
International Immunology
|
June 6, 2018
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia
Nathaniel J Buteyn, Kavin Fatehchand, Ramasamy Santhanam, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys
Razelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Frontiers in Immunology
|
October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
Steven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Scientific Reports
|
November 15, 2017
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Molecular Cancer
|
June 26, 2010
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
Matthew A Bill, James R Fuchs, Chenglong Li, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
ACS Applied Nano Materials
|
May 24, 2021
Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
Lorena P Suarez-Kelly, Steven H Sun, Casey Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
Howard A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Molecular Cancer Research : MCR
|
November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
Himanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 16, 2011
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production
Alena Cristina Jaime-Ramirez, Bethany L Mundy-Bosse, SriVidya Kondadasula, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 272) with videos related to
Sort By:
Page
of 28
International Immunology
|
June 6, 2018
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia
Nathaniel J Buteyn, Kavin Fatehchand, Ramasamy Santhanam, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys
Razelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Frontiers in Immunology
|
October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
Steven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Scientific Reports
|
November 15, 2017
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Molecular Cancer
|
June 26, 2010
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
Matthew A Bill, James R Fuchs, Chenglong Li, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
ACS Applied Nano Materials
|
May 24, 2021
Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
Lorena P Suarez-Kelly, Steven H Sun, Casey Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
Howard A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Molecular Cancer Research : MCR
|
November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
Himanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 16, 2011
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production
Alena Cristina Jaime-Ramirez, Bethany L Mundy-Bosse, SriVidya Kondadasula, et al.
Page
of 28